Erbe Elektromedizin GmbH, a leading global medical technology company, have announced the successful clinical adoption of HYBRIDknife® flex, their newest addition to their hydrodissection and electrosurgical devices. This follows the first human cases, guided by Prof. Alessandro Repici and Prof. Roberta Maselli at Humanitas Research Hospital in Milan, Italy.
The HYBRIDknife® flex is a multifunctional device which combines waterjet technology, precise functions and features specifically designed for colorectal ESD. This needle-free device provides more reliable separation and expansion of the submucosal tissue layer with no need for instrument exchange, as well as precise cutting with limited thermal damage.
Prof. Alessandro Repici, Chairman of Department of Gastroenterology and Hepatology at Humanitas Research Hospital commented “This is an historical time for us as endoscopists. We had the privilege of using [the HYBRIDknife® flex] for the first time in human cases and it is going to be a true game changer for ESD and third space procedures.”
The HYBRIDknife® flex comes in I and T-types, and both come in two different electrode lengths. It allows physicians to perform all four essential steps of an ESD without changing the instrument and comes with CE marking, with Erbe having submitted an application to the U.S. Food and Drug Administration (FDA) for regulatory approval.
Mariuccia Zambelli, Vice President Global Marketing at Erbe Elektromedizin GmbH said “We are very excited to announce the first in human cases with our latest addition to the Erbe HYBRIDknife® portfolio. We expect HYBRIDknife® flex to be commercially available in 2024.”
Erbe Elektromedizin GmbH, a global leader in medical technology, have announced the successful clinical adoption of HYBRIDknife® flex, the latest addition to their portfolio of hydrodissection and electrosurgical devices. This follows the first human cases, guided by Prof. Alessandro Repici and Prof. Roberta Maselli at Humanitas Research Hospital in Milan, Italy.
The HYBRIDknife® flex is a multifunctional device which combines waterjet technology, precise functions and features specifically designed for colorectal ESD, providing more reliable separation and expansion of the submucosal tissue layer with no need for instrument exchange, as well as precise cutting with limited thermal damage. It allows physicians to perform all four essential steps of an ESD without changing the instrument.
Prof. Alessandro Repici, Chairman of Department of Gastroenterology and Hepatology at Humanitas Research Hospital commented “This is an historical time for us as endoscopists. We had the privilege of using [the HYBRIDknife® flex] for the first time in human cases and it is going to be a true game changer for ESD and third space procedures.”
Mariuccia Zambelli, Vice President Global Marketing at Erbe Elektromedizin GmbH said “We are very excited to announce the first in human cases with our latest addition to the Erbe HYBRIDknife® portfolio. We expect HYBRIDknife® flex to be commercially available in 2024.”
The HYBRIDknife® flex has received the CE marking, and Erbe has submitted an application to the U.S. Food and Drug Administration (FDA) for regulatory approval, which will expand the reach of this innovative instrument to healthcare professionals around the world.
Erbe Elektromedizin GmbH have announced the successful clinical adoption of their latest hydrodissection and electrosurgical device, HYBRIDknife® flex. This follows the first human cases, guided by Prof. Alessandro Repici and Prof. Roberta Maselli at Humanitas Research Hospital in Milan, Italy, which were successful in removing two lesions en bloc without complications.
The device is a multifunctional combination of waterjet technology, precise functions and features specifically designed for colorectal ESD, providing more reliable separation and expansion of the submucosal tissue layer with no need for instrument exchange, as well as precise cutting with limited thermal damage. It allows physicians to perform all four essential steps of an ESD without changing the instrument.
Prof. Alessandro Repici commented “This is an historical time for us as endoscopists. We had the privilege of using [the HYBRIDknife® flex] for the first time in human cases and it is going to be a true game changer for ESD and third space procedures.”
Mariuccia Zambelli
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.